Look into the Future

Biomedical Imaging

Research Opportunity   Forecast

Investigate new molecular imaging techniques; Facilitate greater access to these technologies and other short-lived molecular probes, e.g., positron emission tomography for measurement of DNA synthesis and tumor proliferation (F-18 thymidine, C-11 methionine), magnetic resonance spectroscopy (citrate/choline ratios)   Characterization of cells (normal and abnormal) and imaging gene expression and cellular events; for tumors, quantification of blood flow, including angiogenesis, biodistribution of chemotherapeutic agents, and identification of more specific chemotherapy and radiotherapy as well as associated responses to them

Develop and expand access to micro-computed tomography, magnetic resonance imaging, positron emission tomography, and optical technologies for small-animal imaging facilities   Direct in vivo testing of molecular imaging techniques

Develop and integrate image guidance for minimally invasive procedures   Direct delivery of therapy to diseases sites: e.g., combined magnetic resonance/ ultrasonography-guided prostate cancer treatments, magnetic resonance-guided vascular plaque visualization and treatment delivery, and direct visualization of delivery of treatment (e.g., focused ultrasonography for brain or prostate tumors)

Develop technology to allow for multimodal image display and integration   Direct correlation of functional/molecular imaging data into a high spatial resolution image (e.g., computed tomography or magnetic resonance imaging) for radiation therapy planning, tumor ablation therapy, and assessment of therapeutic response

Identify appropriate uses of new imaging modes and tumor markers for disease screening   Evaluation of imaging for screening for detection of lung and colon cancer as well as in assessment of risk of cardiac disease

Expand and integrate bioinformatics and evidence-based imaging algorithms   Rational science-based use of imaging technologies


Authors: Clare M.C. Tempany, MD, Department of Radiology, Brigham and Women's Hospital and Harvard Medical School; Barbara J. McNeil, MD, PhD, Departments of Radiology and Health Care Policy, Brigham and Women's Hospital and Harvard Medical School